ACT-1004-1239
Product Specifications
CAS Number
2178049-58-4
Target
CXCR
Related Pathways
Immunology/Inflammation|||GPCR/G Protein|||Autophagy
Purity
0.9831
Bioactivity
ACT-1004-1239 is an orally active, selective, and potent CXCR7 antagonist with immune-modulatory and myelin-promoting effects. It can be used to study inflammatory demyelinating diseases.
Smiles
N(C(=O)[C@@H]1[C@@H](NC(=O)C=2C=C(ON2)C3=C(F)C=C(F)C=C3)CCN(CC4CC4)C1)C5(CC5)C=6N=CC=CN6
Molecular Formula
C27H28F2N6O3
Molecular Weight
522.55
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
M1499-01J-FITC 100 µL
Mad1 (Mitotic spindle assembly checkpoint protein MAD1, Mitotic arrest deficient-like protein 1, Mitotic checkpoint MAD1 protein homolog) (FITC) discontinued
Ask
View Details 
BDA1084 1 mg
Anti-SARS-CoV-2 Spike RBD (Omicron Reactive), Mouse monoclonal antibody New!
Ask
View Details 